Lucid Diagnostics closes $15.3M registered direct offering of 13.9M shares at $1.10/share

Lucid Diagnostics Inc.

Closed offering of 13,939,331 common shares at $1.10 per share for gross proceeds of $15.3M.
Net proceeds after fees and expenses estimated at $14.5M; Canaccord Genuity acted as sole placement agent.
Funds to be used for working capital and other general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.